Abstract
Intravenous cyclosporin (with or without continued intravenous corticosteroids) is effective in 50-80% of patients with severe ulcerative colitis. An initial dose of 2 mg/kg/day intravenous cyclosporin appears to be as effective as 4 mg/kg/day and is thus preferred from the standpoint of safety. Long term response rates following short term treatment with intravenous cyclosporin in controlled trials ranged from 45% (without azathioprine maintenance) to 78% (with azathioprine). There is a small risk of opportunistic infection and death (1-2%) during combined cyclosporin, corticosteroid, and azathioprine therapy, but lower doses of cyclosporin may improve the safety profile. Toxicity may be reduced at a dose of 2 mg/kg/day intravenous cyclosporin.
Original language | English (US) |
---|---|
Pages (from-to) | 172-173 |
Number of pages | 2 |
Journal | Gut |
Volume | 52 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2003 |
ASJC Scopus subject areas
- Gastroenterology